Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/epivax-y-cubrc-obtienen-contrato-con-la-fda-para-el-desarrollo-de-peptidos-de-control-302286121.html
20 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/epivax-licenses-ispri-toolkit-to-eisai-for-preclinical-in-silico-immunogenicity-screening-302020194.html
10 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/epivax-and-zoetis-to-collaborate-on-swine-t-cell-epitope-prediction-tool-circomatch-301715606.html
09 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/01/09/2585082/0/en/GreenLight-Biosciences-and-Epivax-Therapeutics-Sign-Exclusive-Collaboration-Agreement-to-Develop-Personalized-Cancer-Vaccines.html
31 Oct 2022
// PHARMABIZ
12 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/epivax-secures-additional-funding-from-fda-for-immunogenicity-risk-assessment-for-biosimilar-products-301621585.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?